Inhibition of the G2 DNA Damage Checkpoint and of Protein Kinases Chk1 and Chk2 by the Marine Sponge Alkaloid Debromohymenialdisine

Darko Curman, Bruno Cinel, David E. Williams, Natalie Rundle, Wesley D. Block, Aaron A. Goodarzi, James R. Hutchins, Paul R. Clarke, Bin Bing Zhou, Susan P. Lees-Miller, Raymond J. Andersen, Michel Roberge

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Cells can respond to DNA damage by activating checkpoints that delay cell cycle progression and allow time for DNA repair. Chemical inhibitors of the G2 phase DNA damage checkpoint may be used as tools to understand better how the checkpoint is regulated and may be used to sensitize cancer cells to DNA-damaging therapies. However, few inhibitors are known. We used a cell-based assay to screen natural extracts for G2 checkpoint inhibitors and identified debromohymenialdisine (DBH) from a marine sponge. DBH is distinct structurally from previously known G2 checkpoint inhibitors. It inhibited the G2 checkpoint with an IC50 of 8 μM and showed moderate cytotoxicity (IC50 = 25 μM) toward MCF-7 cells. DBH inhibited the checkpoint kinases Chk1 (IC50 = 3 μM) and Chk2 (IC50 = 3.5 μM) but not ataxiatelangiectasia mutated (ATM), ATM-Rad3-related protein, or DNA-dependent protein kinase in vitro, indicating that it blocks two major branches of the checkpoint pathway downstream of ATM. It did not cause the activation or inhibition of different signal transduction proteins, as determined by mobility shift analysis in Western blots, suggesting that it inhibits a narrow range of protein kinases in vivo.

Original languageEnglish
Pages (from-to)17914-17919
Number of pages6
JournalJournal of Biological Chemistry
Volume276
Issue number21
DOIs
Publication statusPublished - 25 Jan 2001

Fingerprint

Checkpoint Kinase 2
Porifera
Alkaloids
Protein Kinases
Inhibitory Concentration 50
DNA Damage
DNA
Cells
DNA-Activated Protein Kinase
Signal transduction
G2 Phase
MCF-7 Cells
Cytotoxicity
Cell Cycle Checkpoints
DNA Repair
Genetic Therapy
Assays
Signal Transduction
Proteins
Repair

Cite this

Curman, Darko ; Cinel, Bruno ; Williams, David E. ; Rundle, Natalie ; Block, Wesley D. ; Goodarzi, Aaron A. ; Hutchins, James R. ; Clarke, Paul R. ; Zhou, Bin Bing ; Lees-Miller, Susan P. ; Andersen, Raymond J. ; Roberge, Michel. / Inhibition of the G2 DNA Damage Checkpoint and of Protein Kinases Chk1 and Chk2 by the Marine Sponge Alkaloid Debromohymenialdisine. In: Journal of Biological Chemistry. 2001 ; Vol. 276, No. 21. pp. 17914-17919.
@article{09dbe97d9e1e4d5a888d4c7200d196d2,
title = "Inhibition of the G2 DNA Damage Checkpoint and of Protein Kinases Chk1 and Chk2 by the Marine Sponge Alkaloid Debromohymenialdisine",
abstract = "Cells can respond to DNA damage by activating checkpoints that delay cell cycle progression and allow time for DNA repair. Chemical inhibitors of the G2 phase DNA damage checkpoint may be used as tools to understand better how the checkpoint is regulated and may be used to sensitize cancer cells to DNA-damaging therapies. However, few inhibitors are known. We used a cell-based assay to screen natural extracts for G2 checkpoint inhibitors and identified debromohymenialdisine (DBH) from a marine sponge. DBH is distinct structurally from previously known G2 checkpoint inhibitors. It inhibited the G2 checkpoint with an IC50 of 8 μM and showed moderate cytotoxicity (IC50 = 25 μM) toward MCF-7 cells. DBH inhibited the checkpoint kinases Chk1 (IC50 = 3 μM) and Chk2 (IC50 = 3.5 μM) but not ataxiatelangiectasia mutated (ATM), ATM-Rad3-related protein, or DNA-dependent protein kinase in vitro, indicating that it blocks two major branches of the checkpoint pathway downstream of ATM. It did not cause the activation or inhibition of different signal transduction proteins, as determined by mobility shift analysis in Western blots, suggesting that it inhibits a narrow range of protein kinases in vivo.",
author = "Darko Curman and Bruno Cinel and Williams, {David E.} and Natalie Rundle and Block, {Wesley D.} and Goodarzi, {Aaron A.} and Hutchins, {James R.} and Clarke, {Paul R.} and Zhou, {Bin Bing} and Lees-Miller, {Susan P.} and Andersen, {Raymond J.} and Michel Roberge",
year = "2001",
month = "1",
day = "25",
doi = "10.1074/jbc.M100728200",
language = "English",
volume = "276",
pages = "17914--17919",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology",
number = "21",

}

Curman, D, Cinel, B, Williams, DE, Rundle, N, Block, WD, Goodarzi, AA, Hutchins, JR, Clarke, PR, Zhou, BB, Lees-Miller, SP, Andersen, RJ & Roberge, M 2001, 'Inhibition of the G2 DNA Damage Checkpoint and of Protein Kinases Chk1 and Chk2 by the Marine Sponge Alkaloid Debromohymenialdisine', Journal of Biological Chemistry, vol. 276, no. 21, pp. 17914-17919. https://doi.org/10.1074/jbc.M100728200

Inhibition of the G2 DNA Damage Checkpoint and of Protein Kinases Chk1 and Chk2 by the Marine Sponge Alkaloid Debromohymenialdisine. / Curman, Darko; Cinel, Bruno; Williams, David E.; Rundle, Natalie; Block, Wesley D.; Goodarzi, Aaron A.; Hutchins, James R.; Clarke, Paul R.; Zhou, Bin Bing; Lees-Miller, Susan P.; Andersen, Raymond J.; Roberge, Michel.

In: Journal of Biological Chemistry, Vol. 276, No. 21, 25.01.2001, p. 17914-17919.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inhibition of the G2 DNA Damage Checkpoint and of Protein Kinases Chk1 and Chk2 by the Marine Sponge Alkaloid Debromohymenialdisine

AU - Curman, Darko

AU - Cinel, Bruno

AU - Williams, David E.

AU - Rundle, Natalie

AU - Block, Wesley D.

AU - Goodarzi, Aaron A.

AU - Hutchins, James R.

AU - Clarke, Paul R.

AU - Zhou, Bin Bing

AU - Lees-Miller, Susan P.

AU - Andersen, Raymond J.

AU - Roberge, Michel

PY - 2001/1/25

Y1 - 2001/1/25

N2 - Cells can respond to DNA damage by activating checkpoints that delay cell cycle progression and allow time for DNA repair. Chemical inhibitors of the G2 phase DNA damage checkpoint may be used as tools to understand better how the checkpoint is regulated and may be used to sensitize cancer cells to DNA-damaging therapies. However, few inhibitors are known. We used a cell-based assay to screen natural extracts for G2 checkpoint inhibitors and identified debromohymenialdisine (DBH) from a marine sponge. DBH is distinct structurally from previously known G2 checkpoint inhibitors. It inhibited the G2 checkpoint with an IC50 of 8 μM and showed moderate cytotoxicity (IC50 = 25 μM) toward MCF-7 cells. DBH inhibited the checkpoint kinases Chk1 (IC50 = 3 μM) and Chk2 (IC50 = 3.5 μM) but not ataxiatelangiectasia mutated (ATM), ATM-Rad3-related protein, or DNA-dependent protein kinase in vitro, indicating that it blocks two major branches of the checkpoint pathway downstream of ATM. It did not cause the activation or inhibition of different signal transduction proteins, as determined by mobility shift analysis in Western blots, suggesting that it inhibits a narrow range of protein kinases in vivo.

AB - Cells can respond to DNA damage by activating checkpoints that delay cell cycle progression and allow time for DNA repair. Chemical inhibitors of the G2 phase DNA damage checkpoint may be used as tools to understand better how the checkpoint is regulated and may be used to sensitize cancer cells to DNA-damaging therapies. However, few inhibitors are known. We used a cell-based assay to screen natural extracts for G2 checkpoint inhibitors and identified debromohymenialdisine (DBH) from a marine sponge. DBH is distinct structurally from previously known G2 checkpoint inhibitors. It inhibited the G2 checkpoint with an IC50 of 8 μM and showed moderate cytotoxicity (IC50 = 25 μM) toward MCF-7 cells. DBH inhibited the checkpoint kinases Chk1 (IC50 = 3 μM) and Chk2 (IC50 = 3.5 μM) but not ataxiatelangiectasia mutated (ATM), ATM-Rad3-related protein, or DNA-dependent protein kinase in vitro, indicating that it blocks two major branches of the checkpoint pathway downstream of ATM. It did not cause the activation or inhibition of different signal transduction proteins, as determined by mobility shift analysis in Western blots, suggesting that it inhibits a narrow range of protein kinases in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0242659422&partnerID=8YFLogxK

U2 - 10.1074/jbc.M100728200

DO - 10.1074/jbc.M100728200

M3 - Article

C2 - 11279124

AN - SCOPUS:0242659422

VL - 276

SP - 17914

EP - 17919

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 21

ER -